By vgreene, 10 October, 2020 Lopinavir Ritonavir in Patients Admitted to Hospital With COVID 19 RECOVERY A Randomised Controlled Open Label Platform Trial
By vgreene, 10 October, 2020 Long-term Hydroxychloroquine Use in Patients With Rheumatic Conditions and Development of SARS-CoV-2 Infection: A Retrospective Cohort Study; <a href=https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30305-2/fulltext><b><u>access full-tex
By vgreene, 10 October, 2020 <a href=https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2771265><b><u>Access <i>JAMA Intern Med</i> article</u></b></a>
By vgreene, 10 October, 2020 <b>Study considerations:</b> terminated early for futility before reaching enrollment of 200 participants; small sample size; did not quantify exposures or timing of exposures
By vgreene, 10 October, 2020 No significant difference in SARS-CoV-2 infxn rate at 8wk; mild adverse effects in HCQ group; no difference in median QTc change; 6 of 8 participants w/ positive SARS-CoV-2 developed sx, no hospitalization, and all clinically recovered
By vgreene, 10 October, 2020 Double-blinded RCT; 125 hospital-based HCWs (median age 33y) w/ confirmed negative SARS-CoV-2 received HCQ 600 mg daily (n=64) or placebo (n=61) x8wk
By vgreene, 10 October, 2020 Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre exposure SARS CoV 2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial
By vgreene, 10 October, 2020 Azithromycin in Addition to Standard of Care Versus Standard of Care Alone in the Treatment of Patients Admitted to the Hospital With Severe COVID-19 in Brazil (COALITION II): A Randomised Clinical Trial; <a href=https://www.thelancet.com/journals/lancet/
By vgreene, 10 October, 2020 See <a href=https://clinicaltrials.gov/ct2/results?cond=&term=covid+IVIG&cntry=&state=&city=&dist=&Search=Search><b><u>all immune globulin trials</u></b></a>, including international
By vgreene, 10 October, 2020 See <a href=https://clinicaltrials.gov/ct2/results?cond=&term=covid+IVIG&cntry=US&state=&city=&dist=><b><u>U.S. immune globulin trials</u></b></a>
